Surgery for hepatic neuroendocrine tumors: A single institutional experience in Japan

Taizo Hibi, Tsuyoshi Sano, Yoshihiro Sakamoto, Yu Takahashi, Norihisa Uemura, Hidenori Ojima, Kazuaki Shimada, Tomoo Kosuge

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Surgical resection has been advocated as an effective treatment for hepatic neuroendocrine tumors (HNETs) in Western countries, but few data are available to define indications. We evaluated the results of Japanese patients to determine the prognostic factors and the feasibility of our aggressive surgical approach. Methods: The records of all consecutive patients who underwent surgical resection HNETs at our institution were retrospectively reviewed. Patients were selected for surgery all tumors were deemed resectable, regardless of their extent. Results: A total of 21 patients were identified. Bilobar disease was present in 13 patients (62%). Eleven patients (52%) underwent major hepatectomy, which included right trisectionectomy, extended right or left hepatectomy and right hepatectomy. No in-hospital death occurred. The overall 1-, 3- and 5-year survival rates were 95, 68 and 41%, respectively, with a median follow-up of 34 months. Metastatic HNETs from bronchopulmonary primaries exhibited significantly poor outcome compared with other primary sites (P = 0.04). Patients who underwent curative resection had an improved overall 5-year survival rate of 73% compared with palliative resection (0%, P = 0.01). The longest survival in the latter group was months. Complete symptom resolution rate was 92%. Conclusions: This is the first study from Asia demonstrating the safety of aggressive hepatic resection for HNETs. Significant symptom relief and long-term survival were achieved irrespective of the extent of disease or the magnitude of operation. Metastatic HNETs from bronchopulmonary primaries may represent a more lethal subset of tumors.

Original languageEnglish
Pages (from-to)102-107
Number of pages6
JournalJapanese Journal of Clinical Oncology
Volume37
Issue number2
DOIs
Publication statusPublished - 2007 Feb
Externally publishedYes

Fingerprint

Neuroendocrine Tumors
Japan
Liver
Hepatectomy
Survival Rate
Survival
Neoplasms
Safety

Keywords

  • Hepatectomy
  • Neoplasm metastasis
  • Neuroendocrine tumors

ASJC Scopus subject areas

  • Oncology

Cite this

Surgery for hepatic neuroendocrine tumors : A single institutional experience in Japan. / Hibi, Taizo; Sano, Tsuyoshi; Sakamoto, Yoshihiro; Takahashi, Yu; Uemura, Norihisa; Ojima, Hidenori; Shimada, Kazuaki; Kosuge, Tomoo.

In: Japanese Journal of Clinical Oncology, Vol. 37, No. 2, 02.2007, p. 102-107.

Research output: Contribution to journalArticle

Hibi, T, Sano, T, Sakamoto, Y, Takahashi, Y, Uemura, N, Ojima, H, Shimada, K & Kosuge, T 2007, 'Surgery for hepatic neuroendocrine tumors: A single institutional experience in Japan', Japanese Journal of Clinical Oncology, vol. 37, no. 2, pp. 102-107. https://doi.org/10.1093/jjco/hyl140
Hibi, Taizo ; Sano, Tsuyoshi ; Sakamoto, Yoshihiro ; Takahashi, Yu ; Uemura, Norihisa ; Ojima, Hidenori ; Shimada, Kazuaki ; Kosuge, Tomoo. / Surgery for hepatic neuroendocrine tumors : A single institutional experience in Japan. In: Japanese Journal of Clinical Oncology. 2007 ; Vol. 37, No. 2. pp. 102-107.
@article{31e7660c055645598b5e888ad4c9718e,
title = "Surgery for hepatic neuroendocrine tumors: A single institutional experience in Japan",
abstract = "Background: Surgical resection has been advocated as an effective treatment for hepatic neuroendocrine tumors (HNETs) in Western countries, but few data are available to define indications. We evaluated the results of Japanese patients to determine the prognostic factors and the feasibility of our aggressive surgical approach. Methods: The records of all consecutive patients who underwent surgical resection HNETs at our institution were retrospectively reviewed. Patients were selected for surgery all tumors were deemed resectable, regardless of their extent. Results: A total of 21 patients were identified. Bilobar disease was present in 13 patients (62{\%}). Eleven patients (52{\%}) underwent major hepatectomy, which included right trisectionectomy, extended right or left hepatectomy and right hepatectomy. No in-hospital death occurred. The overall 1-, 3- and 5-year survival rates were 95, 68 and 41{\%}, respectively, with a median follow-up of 34 months. Metastatic HNETs from bronchopulmonary primaries exhibited significantly poor outcome compared with other primary sites (P = 0.04). Patients who underwent curative resection had an improved overall 5-year survival rate of 73{\%} compared with palliative resection (0{\%}, P = 0.01). The longest survival in the latter group was months. Complete symptom resolution rate was 92{\%}. Conclusions: This is the first study from Asia demonstrating the safety of aggressive hepatic resection for HNETs. Significant symptom relief and long-term survival were achieved irrespective of the extent of disease or the magnitude of operation. Metastatic HNETs from bronchopulmonary primaries may represent a more lethal subset of tumors.",
keywords = "Hepatectomy, Neoplasm metastasis, Neuroendocrine tumors",
author = "Taizo Hibi and Tsuyoshi Sano and Yoshihiro Sakamoto and Yu Takahashi and Norihisa Uemura and Hidenori Ojima and Kazuaki Shimada and Tomoo Kosuge",
year = "2007",
month = "2",
doi = "10.1093/jjco/hyl140",
language = "English",
volume = "37",
pages = "102--107",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Surgery for hepatic neuroendocrine tumors

T2 - A single institutional experience in Japan

AU - Hibi, Taizo

AU - Sano, Tsuyoshi

AU - Sakamoto, Yoshihiro

AU - Takahashi, Yu

AU - Uemura, Norihisa

AU - Ojima, Hidenori

AU - Shimada, Kazuaki

AU - Kosuge, Tomoo

PY - 2007/2

Y1 - 2007/2

N2 - Background: Surgical resection has been advocated as an effective treatment for hepatic neuroendocrine tumors (HNETs) in Western countries, but few data are available to define indications. We evaluated the results of Japanese patients to determine the prognostic factors and the feasibility of our aggressive surgical approach. Methods: The records of all consecutive patients who underwent surgical resection HNETs at our institution were retrospectively reviewed. Patients were selected for surgery all tumors were deemed resectable, regardless of their extent. Results: A total of 21 patients were identified. Bilobar disease was present in 13 patients (62%). Eleven patients (52%) underwent major hepatectomy, which included right trisectionectomy, extended right or left hepatectomy and right hepatectomy. No in-hospital death occurred. The overall 1-, 3- and 5-year survival rates were 95, 68 and 41%, respectively, with a median follow-up of 34 months. Metastatic HNETs from bronchopulmonary primaries exhibited significantly poor outcome compared with other primary sites (P = 0.04). Patients who underwent curative resection had an improved overall 5-year survival rate of 73% compared with palliative resection (0%, P = 0.01). The longest survival in the latter group was months. Complete symptom resolution rate was 92%. Conclusions: This is the first study from Asia demonstrating the safety of aggressive hepatic resection for HNETs. Significant symptom relief and long-term survival were achieved irrespective of the extent of disease or the magnitude of operation. Metastatic HNETs from bronchopulmonary primaries may represent a more lethal subset of tumors.

AB - Background: Surgical resection has been advocated as an effective treatment for hepatic neuroendocrine tumors (HNETs) in Western countries, but few data are available to define indications. We evaluated the results of Japanese patients to determine the prognostic factors and the feasibility of our aggressive surgical approach. Methods: The records of all consecutive patients who underwent surgical resection HNETs at our institution were retrospectively reviewed. Patients were selected for surgery all tumors were deemed resectable, regardless of their extent. Results: A total of 21 patients were identified. Bilobar disease was present in 13 patients (62%). Eleven patients (52%) underwent major hepatectomy, which included right trisectionectomy, extended right or left hepatectomy and right hepatectomy. No in-hospital death occurred. The overall 1-, 3- and 5-year survival rates were 95, 68 and 41%, respectively, with a median follow-up of 34 months. Metastatic HNETs from bronchopulmonary primaries exhibited significantly poor outcome compared with other primary sites (P = 0.04). Patients who underwent curative resection had an improved overall 5-year survival rate of 73% compared with palliative resection (0%, P = 0.01). The longest survival in the latter group was months. Complete symptom resolution rate was 92%. Conclusions: This is the first study from Asia demonstrating the safety of aggressive hepatic resection for HNETs. Significant symptom relief and long-term survival were achieved irrespective of the extent of disease or the magnitude of operation. Metastatic HNETs from bronchopulmonary primaries may represent a more lethal subset of tumors.

KW - Hepatectomy

KW - Neoplasm metastasis

KW - Neuroendocrine tumors

UR - http://www.scopus.com/inward/record.url?scp=34250881497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250881497&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyl140

DO - 10.1093/jjco/hyl140

M3 - Article

C2 - 17234654

AN - SCOPUS:34250881497

VL - 37

SP - 102

EP - 107

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 2

ER -